This observational study is looking at how neurocysticercosis (NCC), a brain disease caused by the pork tapeworm, progresses in people who are receiving treatment. Researchers want to understand the disease's course during and after treatment with medications like praziquantel and/or albendazole, along with anti-inflammatory drugs. They will also look for new ways to detect the infection and understand how the parasite interacts with the body. You may be able to join if you are 3 years or older and have proven or likely NCC. If you are 18 or older and have been exposed to NCC, you might also be eligible. The study aims to describe how the disease appears, how it affects people, and how they respond to treatment over a long period.

Study design

This is an observational study with a planned enrollment of 500 participants. It is designed to follow participants with cysticercosis during and after treatment.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed long-term to characterize the biochemical and clinical course of neurocysticercosis during and after treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.